Onderneming Cytori Therapeutics Inc Nasdaq
Aandelen
US23283K1051
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 0 | 100,0 % | 5 | 100,0 % | +2.093,30% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 5 | 100,0 % | +2.093,30% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01-10-02 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 06-02-20 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 27-07-23 |
Russ Havranek
PRN | Corporate Officer/Principal | - | 01-01-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01-10-02 |
Richard Hawkins
CHM | Chairman | 75 | 01-12-07 |
Robert Lenk
BRD | Director/Board Member | 75 | 01-03-20 |
J. Clowes
BRD | Director/Board Member | 70 | 01-03-20 |
Greg Petersen
BRD | Director/Board Member | 61 | 14-02-20 |
Director/Board Member | 64 | 01-01-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 962 644 | 5 593 930 ( 93,82 %) | 258 425 ( 4,334 %) | 93,82 % |
Bedrijfsgegevens
Plus Therapeutics, Inc.
4200 Marathon Boulevard Suite 200
78756, Austin
+737 255 7194
http://www.plustherapeutics.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,41% | 45,51 mld. | |
+38,65% | 38,13 mld. | |
-8,62% | 38,52 mld. | |
+26,95% | 30,74 mld. | |
-13,50% | 26,03 mld. | |
+10,74% | 25,92 mld. | |
+44,87% | 14,13 mld. | |
+34,36% | 12,73 mld. | |
-7,14% | 11,29 mld. |